Nuvalent Inc vs Schlumberger NV — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Schlumberger NV trades at $46.6 (market cap $69.36B). The key difference: Schlumberger NV is far larger — about 7.1× Nuvalent Inc's market cap, and Schlumberger NV pays a 2.54% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | SLB | |
|---|---|---|
Market Cap | $9.81B | $69.36B |
Sector | Technology | Energy |
52-Week High | $123.96 | $58.01 |
52-Week Low | $72.16 | $31.72 |
Enterprise Value | $8.52B | $77.58B |
Dividend Yield | — | 2.54% |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →